Tandlægeholdingselskabet Marianne Bækø ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 10.9% 13.3% 14.9% 24.4%  
Credit score (0-100)  0 24 18 15 3  
Credit rating  N/A BB BB BB B  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Gross profit  0.0 -128 -221 -153 -259  
EBITDA  0.0 -806 -1,123 -1,418 -635  
EBIT  0.0 -811 -1,149 -1,418 -635  
Pre-tax profit (PTP)  0.0 166.3 90.7 -132.9 11.0  
Net earnings  0.0 129.4 68.8 -103.9 7.6  
Pre-tax profit without non-rec. items  0.0 166 90.7 -133 11.0  

 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Tangible assets total  0.0 126 0.0 0.0 0.0  
Shareholders equity total  0.0 179 142 38.6 46.2  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 78.0  
Balance sheet total (assets)  0.0 730 688 445 376  

Net Debt  0.0 -415 -629 -18.8 72.0  
 
See the entire balance sheet

Volume 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 -128 -221 -153 -259  
Gross profit growth  0.0% 0.0% -72.6% 31.0% -69.6%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 730 688 445 376  
Balance sheet change%  0.0% 0.0% -5.8% -35.3% -15.6%  
Added value  0.0 -806.4 -1,123.1 -1,392.6 -634.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 121 -151 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 632.3% 519.2% 928.4% 245.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 22.8% 15.5% -20.0% 4.5%  
ROI %  0.0% 89.6% 66.8% -125.1% 22.6%  
ROE %  0.0% 72.1% 42.7% -114.8% 17.9%  

Solidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Equity ratio %  0.0% 24.6% 20.7% 8.7% 12.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 51.4% 56.0% 1.3% -11.3%  
Gearing %  0.0% 0.0% 0.0% 0.0% 169.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 19.0%  

Liquidity 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Quick Ratio  0.0 1.1 1.2 1.1 1.1  
Current Ratio  0.0 1.1 1.2 1.1 1.1  
Cash and cash equivalent  0.0 414.8 629.2 18.8 6.0  

Capital use efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 44.9 128.0 23.6 46.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
N/A
2017
2017/12
2018
2018/12
2019
2019/12
2020
2020/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -1,123 -1,393 -635  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -1,123 -1,418 -635  
EBIT / employee  0 0 -1,149 -1,418 -635  
Net earnings / employee  0 0 69 -104 8